Live Chart

O 472

H 472

L 472

VOL 425

Aarti Pharmalabs Performance

Days Range

Low: ₹459.30
High: ₹478.70
Previous Close ₹472.80
Open ₹472.00
Volume 2,10,290
Day’s Range ₹459.30 - ₹478.70
52W Range ₹234.80 - ₹497.00
Market Cap ₹4,288.42 Cr

Fundamentals of Aarti Pharmalabs

ROCE (TTM) 14.62%
P/E Ratio (TTM) 22.64
P/B Ratio 2.59
Industry P/E 32.13
Debt to Equity 0.13
ROE 11.43%
EPS (TTM) 20.9
Dividend Yield 0.42%
Book Value 183
Face Value 5

Financials of Aarti Pharmalabs

Dec 2022Mar 2023Jun 2023Sep 2023
Net Sales471.62485.06458.36439.8
Expenses401.62421.02390.69369.95
Profit before tax65.0358.8463.9866.94
Operating Profit47.6842.8747.0951.8
Net Profit47.6842.8747.0951.8
EPS in Rs5.264.735.25.72

About Aarti Pharmalabs

Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chem ... Read More

Parent Organisation Indian Private
Founded 2019
Managing Director Rashesh C Gogri
NSE Symbol AARTIPHARM

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,216.90

272.1

3.50 (-1.27%)

270.5 - 281.4
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹48.94

43

1.50 (-3.37%)

43 - 43.95
Procter & Gamble Health Ltd ₹8,308.96

4950.55

53.50 (-1.07%)

4940 - 5035
Veerhealth Care Ltd ₹33.52

26

0.00 (0.00)

26 - 26

What's Trending

FAQs

What is the Share price of Aarti Pharmalabs (AARTIPHARM)?

Aarti Pharmalabs (AARTIPHARM) share price as of December 8, 2023, on NSE is Rs 466.75 (NSE) and Rs 468.45 (BSE) on BSE.

Can I buy Aarti Pharmalabs (AARTIPHARM) shares?

Yes, You can buy Aarti Pharmalabs (AARTIPHARM) shares by opening a Demat account with Angel One.

How do I buy Aarti Pharmalabs (AARTIPHARM) from Angel One?

Aarti Pharmalabs (AARTIPHARM) share can be brought through the following modes:
  1. Direct investment: You can buy Aarti Pharmalabs (AARTIPHARM) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Aarti Pharmalabs (AARTIPHARM) shares.